Brigitte Brux
About
Brigitte Brux is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism.
According to data from OpenAlex, Brigitte Brux has authored 33 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Brigitte Brux's work include Prostate Cancer Diagnosis and Treatment (20 papers), Prostate Cancer Treatment and Research (20 papers) and Molecular Biology Techniques and Applications (5 papers). Brigitte Brux is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (20 papers), Prostate Cancer Treatment and Research (20 papers) and Molecular Biology Techniques and Applications (5 papers). Brigitte Brux collaborates with scholars based in Germany, United States and Canada. Brigitte Brux's co-authors include Klaus Jung, Dietmar Schnorr, Michael Lein, Pranav Sinha, Stefan A. Loening, Birgit Rudolph, Carsten Stephan, Steffen Hauptmann, Wolfgang Henke and S.A. Loening and has published in prestigious journals such as International Journal of Cancer, Clinical Chemistry and European Urology.
In The Last Decade
Brigitte Brux
31 papers receiving 620 citations
Peers
Brigitte Brux
MITCHELL C. CALDWELL United States
Cindy L. Evans United States
Kari Tuhkanen Finland
Marie‐Claude Bettencourt United States
Peggy S. Esper United States
F. Gómez-Veiga Spain
Theo de Reijke Netherlands
Takashi Fukagai Japan
H Knönagel Switzerland
Erik Briers Belgium
Citations per year, relative to Brigitte Brux Brigitte Brux (= 1×)
peers
MITCHELL C. CALDWELL
Countries citing papers authored by Brigitte Brux
Since
Specialization
Citations
This map shows the geographic impact of Brigitte Brux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Brux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Brux more than expected).
Fields of papers citing papers by Brigitte Brux
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Brigitte Brux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Brux. The network helps show where Brigitte Brux may publish in the future.
Co-authorship network of co-authors of Brigitte Brux
This figure shows the co-authorship network connecting the top 25 collaborators of Brigitte Brux. A scholar is included among the top collaborators of Brigitte Brux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitte Brux. Brigitte Brux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Roigas, Jan, S. Değer, Joerg H. Schroeder, et al.. (2003). Tumor type M2 pyruvate kinase expression in metastatic renal cell carcinoma. Urological Research. 31(6). 358–362.
2.
Jakob, Christian, Ivana Zavrski, Ulrike Heider, et al.. (2002). Bone resorption parameters [carboxy‐terminal telopeptide of type‐I collagen (ICTP), amino‐terminal collagen type‐I telopeptide (NTx), and deoxypyridinoline (Dpd)] in MGUS and multiple myeloma. European Journal Of Haematology. 69(1). 37–42.
3.
Stephan, Carsten, Klaus Jung, Henning Cammann, et al.. (2002). An artificial neural network considerably improves the diagnostic power of percent free prostate‐specific antigen in prostate cancer diagnosis: Results of a 5‐year investigation. International Journal of Cancer. 99(3). 466–473.
4.
Jung, Klaus, Carsten Stephan, Brigitte Brux, et al.. (2001). Comparison of the Clinical Validity of Free Prostate–Specific Antigen, Alpha–1 Antichymotrypsin–Bound Prostate–Specific Antigen and Complexed Prostate–Specific Antigen in Prostate Cancer Diagnosis. European Urology. 39(1). 57–64.
5.
Jung, Klaus, Carsten Stephan, Michael Lein, et al.. (2001). Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 ?g/L: Are they useful tools for early detection and screening of prostate cancer?. International Journal of Cancer. 93(5). 759–765.
6.
Jung, Klaus, Carsten Stephan, Michael Lein, et al.. (2001). Receiver-operating characteristic as a tool for evaluating the diagnostic performance of prostate-specific antigen and its molecular forms?What has to be considered?. The Prostate. 46(4). 307–310.
7.
Lein, Michael, Klaus Jung, Axel Semjonow, et al.. (2001). A multicenter clinical trial on the use of alpha1‐antichymotrypsin‐prostate‐specific antigen in prostate cancer diagnosis. The Prostate. 47(2). 77–84.
8.
Stephan, Carsten, Klaus Jung, Brigitte Brux, et al.. (2000). Elimination of Serum Complexed Prostate-Specific Antigen after Radical Retropubic Prostatectomy. Clinical Chemistry and Laboratory Medicine (CCLM). 38(4). 309–311.
9.
Jung, Klaus, Michael Lein, Brigitte Brux, et al.. (2000). Different Stability of Free and Complexed Prostate-Specific Antigen in Serum in Relation to Specimen Handling and Storage Conditions. Clinical Chemistry and Laboratory Medicine (CCLM). 38(12). 1271–5.
10.
Stephan, Carsten, Klaus Jung, Brigitte Brux, et al.. (2000). ACT-PSA and complexed PSA elimination kinetics in serum after radical retropubic prostatectomy: proof of new complex forming of PSA after release into circulation. Urology. 55(4). 560–563.
11.
Jung, Klaus, Michael Lein, Brigitte Brux, et al.. (1999). Rapid detection of elevated prostate-specific antigen levels in blood: performance of various membrane strip tests compared. Urology. 53(1). 155–160.
12.
Jung, Klaus, Brigitte Brux, Michael Lein, et al.. (1999). A Gap Between Total Prostate-specific Antigen and the Sum of Free Prostate-specific Antigen Plus α1-Antichymotrypsin-Prostate-specific Antigen in Patients with Prostate Carcinoma but not in Those with Benign Prostate Hyperplasia. Clinical Chemistry. 45(3). 422–424.
13.
Jung, Klaus, Brigitte Brux, Michael Lein, et al.. (1999). Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA. Urology. 53(6). 1160–1167.
14.
Wenger, F. A., Brigitte Brux, Joachim Müller, et al.. (1998). K-ras mutations in stools and tissue samples from patients with malignant and nonmalignant pancreatic diseases. Clinical Chemistry. 44(10). 2103–2107.
15.
Lein, Michael, Brigitte Brux, Klaus Jung, et al.. (1997). Elimination of Serum Free and Total Prostate-Specific Antigen after Radical Retropubic Prostatectomy. Clinical Chemistry and Laboratory Medicine (CCLM). 35(8). 591–5.
16.
Bollmann, R, et al.. (1996). ASSESSMENT OF SERUM LEVELS OF α-1-MICROGLOBULIN, β-2-MICROGLOBULIN, AND RETINOL BINDING PROTEIN IN THE FETAL BLOOD. A METHOD FOR PRENATAL EVALUATION OF RENAL FUNCTION. Prenatal Diagnosis. 16(4). 299–305.
17.
Lun, Andreas, Friedrich Priem, Brigitte Brux, et al.. (1994). Biochemical diagnosis in prenatal uropathy. Clinical Biochemistry. 27(4). 283–287.
18.
Brux, Brigitte, et al.. (1992). Effects of postnatal ganglioside administration and hypoxia-exposure on the dopamine release from striatal slices, the behaviour and the ganglioside pattern of 2?3 months old rats. Journal of Neural Transmission. 87(2). 105–112.
19.
Brux, Brigitte, et al.. (1992). Lasting effects of postnatal hypoxia and saline injection on the striatal dopamine transport and their modification by gangliosides. Neurochemistry International. 20(3). 385–389.
20.
Michel, Sylvie, et al.. (1978). [Effect of temperature on formation of lysozyme in E. coli CRT 266 (dnaB ts) after infection with bacteriophage T3].. PubMed. 37(11-12). 1639–44.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by MITCHELL C. CALDWELL Breakdown of academic impact, for papers by Cindy L. Evans Breakdown of academic impact, for papers by Kari Tuhkanen Breakdown of academic impact, for papers by Marie‐Claude Bettencourt Breakdown of academic impact, for papers by Peggy S. Esper Breakdown of academic impact, for papers by F. Gómez-Veiga Breakdown of academic impact, for papers by Theo de Reijke Breakdown of academic impact, for papers by Takashi Fukagai Breakdown of academic impact, for papers by H Knönagel Breakdown of academic impact, for papers by Erik Briers